25Sep 2021
Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes

Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes

Limited data exist about the use of insulin degludec in the hospital. This multicentre, non‐inferiority, open‐label, prospective randomized trial compared the safety and efficacy of insulin degludec‐U100 and glargine‐U100 for the management of hospitalized patients with type 2 diabetes.Hospital treatment with degludec‐U100 or glargine‐U100 is equally safe and effective for the management of hyperglycaemia in general medical and surgical patients with type 2 diabetes.

  • #endo-diabetology

Like

Save

Share